GlassScriptPhysician profile
Bryla N Simpson
NPI 1487052379
$627.33
in general payments reported to CMS, 2019-2025
12 companies · $264 in 2025
The $264 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $28.57 · 2022: $125 · 2023: $164 · 2024: $46.29 · 2025: $264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $474.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $473.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $223.11 | 2021-2025 | |
| Lilly USA, LLC | $160.17 | 2022-2023 | Mounjaro, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $51.11 | 2023 | |
| Revance Therapeutics, INC. | $50.87 | 2025 | Daxxify |
| Exact Sciences Corporation | $32.39 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Xeris Pharmaceuticals, INC. | $22.86 | 2023 | Gvoke Hypopen |
| Pfizer INC. | $17.39 | 2024 | |
| Amgen INC. | $15.00 | 2024 | Otezla, Repatha |
| Novo Nordisk INC | $14.24 | 2023 | |
| Novartis Pharmaceuticals Corporation | $14.05 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $13.36 | 2023 | Farxiga |
| Glaxosmithkline, LLC. | $12.78 | 2023 | Arexvy, Shingrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryla Simpson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.